Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 47


Assessment of drug-drug interactions between daclatasvir and methadone or buprenorphine-naloxone.

Garimella T, Wang R, Luo WL, Wastall P, Kandoussi H, DeMicco M, Bruce RD, Hwang C, Bertz R, Bifano M.

Antimicrob Agents Chemother. 2015 Sep;59(9):5503-10. doi: 10.1128/AAC.00478-15. Epub 2015 Jun 29.


Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment.

Garimella T, Wang R, Luo WL, Hwang C, Sherman D, Kandoussi H, Marbury TC, Alcorn H, Bertz R, Bifano M.

Antivir Ther. 2015;20(5):535-43. doi: 10.3851/IMP2941. Epub 2015 Feb 5.


A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo.

Liu TQ, Luo WL, Tan X, Fang Y, Chen J, Zhang H, Yu XF, Cai JR, Ding XQ.

Oxid Med Cell Longev. 2014;2014:427560. doi: 10.1155/2014/427560. Epub 2014 Nov 11.


Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone.

Garimella T, Wang R, Luo WL, Wastall P, Kandoussi H, Demicco M, Bruce D, Hwang C, Bertz R, Bifano M.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19628. doi: 10.7448/IAS.17.4.19628. eCollection 2014.


Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects.

Kasichayanula S, Boulton DW, Luo WL, Rodrigues AD, Yang Z, Goodenough A, Lee M, Jemal M, LaCreta F.

Br J Clin Pharmacol. 2014 Nov;78(5):1122-34. doi: 10.1111/bcp.12425.


[Relationship between genetic variation of furin gene and hypercholesterolemia and hyper-low-density lipoprotein cholesterolemia in Kazakh general population].

Wang HM, Li NF, Hong J, Luo WL, Yan ZT, Wang XL, Zhu Y, Shen Y.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014 Apr;36(2):168-75. doi: 10.3881/j.issn.1000-503X.2014.02.010. Chinese.


The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.

De Kam PJ, Luo WL, Wenning L, Ratcliffe L, Sisk CM, Royalty J, Radziszewski W, Wagner JA, Lai E.

Platelets. 2014;25(7):480-7. doi: 10.3109/09537104.2013.836747. Epub 2013 Nov 8.


[Association between sequence variation of Furin gene and obesity in ethnic Kazakh from Xinjiang].

Wang HM, Shen Y, Hong J, Zhou L, Luo WL, Wang XL, Zhu Y, Li NF.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Apr;30(2):227-32. doi: 10.3760/cma.j.issn.1003-9406.2013.04.024. Chinese.


Experimental research on treatment of injured facial nerves induced by hepatocyte growth factor mediated by ultrasound-targeted microbubble destruction.

Hao YN, Luo WL, Wang D, Wang ZG.

J Craniofac Surg. 2013 Mar;24(2):421-4. doi: 10.1097/SCS.0b013e31828010eb.


The effects of simvastatin on the pharmacokinectics of sitagliptin.

Cerra M, Luo WL, Li SX, Matthews C, O'Neill EA, Wagner JA, Stoch SA, Anderson MS.

J Popul Ther Clin Pharmacol. 2012;19(3):e356-60. Epub 2012 Oct 11.


Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.

Lauring B, Taggart AK, Tata JR, Dunbar R, Caro L, Cheng K, Chin J, Colletti SL, Cote J, Khalilieh S, Liu J, Luo WL, Maclean AA, Peterson LB, Polis AB, Sirah W, Wu TJ, Liu X, Jin L, Wu K, Boatman PD, Semple G, Behan DP, Connolly DT, Lai E, Wagner JA, Wright SD, Cuffie C, Mitchel YB, Rader DJ, Paolini JF, Waters MG, Plump A.

Sci Transl Med. 2012 Aug 22;4(148):148ra115. doi: 10.1126/scitranslmed.3003877.


Rigid gas-permeable contact lens for visual rehabilitation in aphakia following trauma.

Luo WL, Tong JP, Shen Y.

Clin Exp Optom. 2012 Sep;95(5):499-505. doi: 10.1111/j.1444-0938.2012.00764.x. Epub 2012 Jul 17.


(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans.

Boatman PD, Lauring B, Schrader TO, Kasem M, Johnson BR, Skinner P, Jung JK, Xu J, Cherrier MC, Webb PJ, Semple G, Sage CR, Knudsen J, Chen R, Luo WL, Caro L, Cote J, Lai E, Wagner J, Taggart AK, Carballo-Jane E, Hammond M, Colletti SL, Tata JR, Connolly DT, Waters MG, Richman JG.

J Med Chem. 2012 Apr 26;55(8):3644-66. doi: 10.1021/jm2010964. Epub 2012 Apr 9.


Pharmacokinetics and pharmacodynamics of once-daily versus twice-daily raltegravir in treatment-naive HIV-infected patients.

Rizk ML, Hang Y, Luo WL, Su J, Zhao J, Campbell H, Nguyen BY, Sklar P, Eron JJ Jr, Wenning L.

Antimicrob Agents Chemother. 2012 Jun;56(6):3101-6. doi: 10.1128/AAC.06417-11. Epub 2012 Mar 19.


[Relationship between rs3865418 polymorphism of neural precursor cell expressed developmentally downregulated 4-like gene and obesity in Kazakh general population].

Wang HM, Hong J, Luo WL, Chang JH, Yao XG, Li NF.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Oct;33(5):533-7. Chinese.


Association of genetic variations of the prostasin gene with essential hypertension in the Xinjiang Kazakh population.

Li NF, Zhang JH, Chang JH, Yang J, Wang HM, Zhou L, Luo WL.

Chin Med J (Engl). 2011 Jul;124(14):2107-12.


A common variation within the STEAP4 gene exons is associated with obesity in Uygur general population.

Guo YY, Li NF, Zhou L, Yao XG, Wang HM, Zhang JH, Luo WL.

Chin Med J (Engl). 2011 Jul;124(14):2096-100.


[Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].

Liang DP, Yao XG, Li NF, Zhang DL, Guo YY, Lin L, Zhou L, Li WC, Yan ZT, Wang HM, Luo WL, Chang JH.

Zhonghua Yu Fang Yi Xue Za Zhi. 2011 May;45(5):440-3. Chinese.


[Association of STEAP4 genetic polymorphisms with insulin resistance in Uygur Chinese general population].

Guo YY, Zhou L, Yao XG, Yan ZT, Wang HM, Luo WL, Shen Y, Li NF.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Jun;33(3):299-305. doi: 10.3881/j.issn.1000-503X.2011.03.018.


[Genetic variations of bone morphogenetic protein 7 gene are associated with hypertriglyceridemia of Uygur Chinese in Xinjiang].

Yan ZT, Li NF, Guo YY, Yao XG, Wang HM, Luo WL, Zhang JH, Hong J, Zhou L.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Mar;39(3):221-7. Chinese.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk